Saturday 10 April 2021
Home      All news      Contact us      RSS      Urdu
RT - 1 month ago

Early data shows Curevac Covid-19 jab backed by Britain and Brussels is effective against UK and South Africa variants, CEO says

Preliminary trials show that a Covid-19 vaccine being developed by German biotech firm Curevac is effective against the UK and South Africa variants of the virus, its CEO Franz-Werner Haas told EU lawmakers on Thursday.
Read Full Article at RT.com


Latest News
Hashtags:   

Early

 | 

shows

 | 

Curevac

 | 

Covid

 | 

backed

 | 

Britain

 | 

Brussels

 | 

effective

 | 

against

 | 

South

 | 

Africa

 | 

variants

 | 

Sources